Kangmei Pharma | 600518 - Des Atouts





Des Atouts Changement Date
Akebia Therapeutics USD 349.66M 12.86M 2026-06
Alaunos Therapeutics USD 1.88M 1.08M 2026-03
Avita Medical AUD 56.39M 1.74M 2025-12
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
Dianthus Therapeutics USD 1.21B 33.61M 2026-06
Genomma Lab Internacional MXN 24.19B 605.51M 2026-06
Hypermarcas BRL 26B 843.02M 2026-03
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
IQVIA Holdings USD 29.88B 206M 2026-06
Jiangsu Hengrui CNY 70.77B 520.74M 2026-06
Kangmei Pharma CNY 13.31B 375.64M 2026-03
Moderna USD 10.96B 527M 2026-06
Organon & Co USD 13.18B 182M 2026-06
Revvity USD 12.05B 49.24M 2026-06
Sh Fosun Pharma CNY 122.97B 2.91B 2026-03
Tectonic Therapeutic USD 246.58M 14.46M 2026-03
Viatris USD 35.04B 1.79B 2026-06
Wuxi Apptec CNY 116.26B 8.85B 2026-06
Xeris Pharmaceuticals USD 411.9M 19.89M 2026-06
Zz Pientze Pharmaceu CNY 18.38B 905.93M 2026-03